Bruker Corporation to Present at Upcoming Investor Conferences
February 20 2025 - 3:01PM
Business Wire
Bruker Corporation (Nasdaq: BRKR) announced today that its
senior leadership will present at the following conferences:
Citi 2025 Unplugged Medtech and Life Sciences Access Day in
New York City Thursday, February 27, 2025, at 2:30 p.m. Eastern
Time
TD Cowen 45th Annual Health Care Conference in Boston, MA
Wednesday, March 5, 2025, at 11:10 a.m. Eastern Time
Barclays 27th Annual Global Healthcare Conference in Miami,
FL Tuesday, March 11, 2025, at 2:30 p.m. Eastern Time
Leerink 2025 Global Healthcare Conference in Miami, FL
Wednesday, March 12, 2025, at 11:20 a.m. Eastern Time
Live audio webcasts of the presentations will be available on
the Investor Relations section of the Company's website at
https://ir.bruker.com. Replays of the presentations will be posted
in the “Events & Presentations” section of the Bruker
Corporation Investor Relations website after the event and will be
available for at least 30 days following the presentations.
About Bruker Corporation – Leader of the Post-Genomic Era
(Nasdaq: BRKR)
Bruker is enabling scientists and engineers to make breakthrough
post-genomic discoveries and develop new applications that improve
the quality of human life. Bruker’s high performance scientific
instruments and high value analytical and diagnostic solutions
enable scientists to explore life and materials at molecular,
cellular, and microscopic levels. In close cooperation with our
customers, Bruker is enabling innovation, improved productivity,
and customer success in post-genomic life science molecular and
cell biology research, in applied and biopharma applications, in
microscopy and nanoanalysis, as well as in industrial and cleantech
research, and next-gen semiconductor metrology in support of AI.
Bruker offers differentiated, high value life science and
diagnostics systems and solutions in preclinical imaging, clinical
phenomics research, proteomics and multiomics, spatial and
single-cell biology, functional structural and condensate biology,
as well as in clinical microbiology and molecular diagnostics. For
more information, please visit www.bruker.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250220095618/en/
Joe Kostka Director, Investor Relations Bruker Corporation T: +1
(978) 313-5800 E: Investor.Relations@bruker.com
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jan 2025 to Feb 2025
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Feb 2024 to Feb 2025